DOLPHIN 3 FLUID MANAGEMENT SYSTEM
Device Facts
| Record ID | K110852 |
|---|---|
| Device Name | DOLPHIN 3 FLUID MANAGEMENT SYSTEM |
| Applicant | Gyrus Acmi, Inc. |
| Product Code | HIG · Obstetrics/Gynecology |
| Decision Date | Jul 19, 2011 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 884.1700 |
| Device Class | Class 2 |
Indications for Use
The DOLPHIN® 3 Fluid Management System provides low viscosity liquid distension of the uterus for hysteroscopy, and monitors intrauterine pressure, fluid use and fluid deficit.
Device Story
The DOLPHIN® 3 is a hysteroscopic insufflator used in clinical settings by physicians to manage uterine distension fluid. It utilizes a two-bag system with pneumatic bladder bags (bag squeezers) within a rigid housing to maintain steady infusion pressure (40-140 mmHg). A disposable tubing set with an integrated pressure transducer delivers fluid to the hysteroscope. The device weighs fluid to calculate and display real-time fluid deficit and intrauterine pressure. It provides audible and visual alarms if pressure or fluid deficit thresholds are exceeded. By maintaining controlled distension, the device facilitates visualization during hysteroscopic procedures. The system supports 1, 2, or 3-liter fluid bags.
Clinical Evidence
Bench testing only. Performance verified through pressure accuracy vs. flow rate testing across multiple hysteroscope models, simulated procedures, load cell overstrain testing, fluid bag/canister compatibility, calibration verification, transducer fault detection, acoustic alarm testing, operational tilt testing, splash testing, and environmental stress testing (vibration/shock).
Technological Characteristics
Hysteroscopic insufflator; pneumatic bladder bag pump system; integrated pressure transducer; load cell-based fluid weighing; LCD/LED interface; EtO-sterilized single-use tubing; compliant with IEC 60601-1, IEC 60601-1-2, and ISO 10993 standards.
Indications for Use
Indicated for patients undergoing hysteroscopy requiring low viscosity liquid uterine distension and monitoring of intrauterine pressure, fluid usage, and fluid deficit.
Regulatory Classification
Identification
A hysteroscopic insufflator is a device designed to distend the uterus by filling the uterine cavity with a liquid or gas to facilitate viewing with a hysteroscope.
Predicate Devices
- Gyrus ACMI DOLPHIN® II Fluid Management System (K011876)
Submission Summary (Full Text)
{0}------------------------------------------------
DOLPHIN® 3 Gyrus ACMI, Inc. 136 Turnpike Road Southborough, MA 01772 Traditional 510(k) 510/k) Summar Mar 25, 2011
## 510(k) Summary of Safety and Effectiveness Gyrus ACMI, Inc. DOLPHIN® 3 Fluid Management System
JUL 19 2011
)
#### General Information
Manufacturer/Submitter:
Gyrus ACMI, Inc 136 Turnpike Rd. Southborough, MA 01772-2104
Establishment Registration Number:
3003790304
March 25, 2011
Contact Person:
Graham A. L. Baillie MS Associate Manager, Regulatory Affairs
Date Prepared:
Device Description
Classification Name:
Hysteroscopic Insufflator Class 2 21 CFR 884.1700 85 HIG
Project Name:
Trade Name(s):
Generic/Common Name:
DOLPHIN® 3
DOLPHIN® 3 Fluid Management System
Hysteroscopic Insufflator
#### Predicate Devices
Gyrus ACMI DOLPHIN® II Fluid Management System
#### Intended Use
The DOLPHIN® 3 Fluid Management System provides low viscosity liquid distension of the uterus for hysteroscopy, and monitors intrauterine pressure, fluid use and fluid deficit.
### Product Description
The DOLPHIN® 3 will be used during Hysteroscopic procedures where physicians need to monitor fluid pressure and fluid loss. The system will provide delivery of low viscosity distension fluid through a disposable tubing set that includes an integrated pressure transducer. The system will calculate and display fluid pressure and fluid deficit while providing distension of the uterus for visualization and flow. The
{1}------------------------------------------------
DOLPHIN® 3 Gyrus ACMI, Inc. 136 Turnpike Road Southborough, MA 01772
K110852
Page 2 of 4
Traditional 510(k) Notification
510(k) Summary
Mar 25, 2011
DOLPHIN® 3 provides both audible and visual alarms if pressure levels are too high or if the user-set fluid deficit alarm levels are exceeded.
The DOLPHIN® 3 incorporates a two-bag distension fluid system that utilizes a bladder bag to provide steady pressure on (each) the fluid bags. The two bladder bags are essentially pneumatic "bag squeezers" set within a rigid housing that contains the fluid bags. The DOLPHIN® 3 fluid pump adjusts the pressure applied to the distension fluid bags by inflating or deflating the pneumatic bladder. The infusion pressure can be set by the user between 40-140 mm Hg (40 mmHg is the factory default setting at power up) The system can accommodate 1, 2 or 3 liter fluid bags, The sterile/disposable tubing set with integrated pressure transducer is used to deliver fluid from the DOLPHIN® 3 to the inflow port on the hysteroscope. The device weighs the fluid in order to calculate the deficit. Any fluid dispensed but not returned to the collection canisters is considered part of the deficit.
#### Summary Listing of Nonclinical/Bench Testing
The following performance/functional tests were conducted to verify that the subject device met specified requirements.
1) Pressure Accuracy vs Flow Rate: Illustrated the intrauterine pressure developed by the DOLPHIN®3 at various output pressures and flow rates. Comparitive testing included three different make/models of hysteroscopes. The intrauterine pressure versus flow data for the predicate and subject devices were plotted for each scope. 2) Simulated Procedure: Verify that fluid management data accuracy and alarm functions are maintained throughout a simulated procedure.
3) Load Cell Overstrain Test: Verify functionality of the mechanical Load Cell protection incorporated in the design of the DOLPHIN®3 Load cell sub assemblies (upper and lower) by applying an overstraining force on the load cells.
4) Fluid Bag and Canister Compatibility Test: The purpose of the test was to verify the equipment is compatible and functions with the recommended manufacturer's fluid bags of various sizes and recommended collection canisters.
5) Calibration Protocol: Verified functionality of the Calibration module and Calibration Verification module. Checked accuracy through the working range of all the load cells in the machine and verified the functionality of the software trigger for Passing/Failing the calibration check.
6) External Transducer Check Test. The purpose of the test was to determine the ability of the subject device to identify faulty external pressure transducers (part of the Tubing Set) due to open wiring connections.
7) Internal Pressure Transducer Check Procedure: Verify the software and hardware pressure cutout limits meet performance specifications.
8) Acoustic Level Test: In all cases alarms were measurably discernible from the pump background noise and audible to the operator.
9) Bladder Bag Inflate/Deflate Test: The purpose of the test was to verify PPS requirements for Bladder Bag inflate/deflate times and flow rates.
10) Operational Tilt Test: Determined the subject device's ability to operate and maintain fluid deficit accuracy, when subjected to an incline and tilt deviation from a normal operational position on a level floor.
{2}------------------------------------------------
DOLPHIN® 3 Gyrus ACMI. Inc. 136 Turnpike Road Southborough, MA 01772
K110852
Page 3 of 4
Traditional 510(k) Notification
510(k) Summary
Mar 25, 2011
i 1) Dolphin 3 Splash Test: This test verified that the DOLPHIN®3 Hysteroscopic Fluid Management System will function within the Product Performance Specifications immediately after being subjected to an in-process splash of conductive solution and also function after allowing a 24 hour drying period to occur
12) Pneumatic Test Protocol: The purpose of the test was to verify pump and pneumatic circuit performance requirements.
13) Operational Environment Test: Verify (1) the subject device operates within its intended operating environment as specified in product performance specifications and (2) that the device continues to operate after exposure to vibration/shock likely to be experienced during use. Proper Dolphin operation was verified by completing the following functional tests:
- LCD and LED Initialization Tests .
- Alarms Initialization Test .
- Calibration Functional Test .
- Fluid Test .
- Inspection for Visible Damage .
14) Pressure vs. Bag Volume: This test characterizes the ability of DOLPHIN 3 to maintain pressure as the irrigation bag drains.
The following standards were referenced in electrical safety, EMC, biocompatibility and sterilization testing:
1) IEC 60601-1, Medical Electrical Equipment - Part 1: General Requirements for Safety, 1988; Amendment 1, 1991-11. Amendment 2, 1995
2) EC 60601-1-2, Medical electrical equipment - Part 1-2: General Requirements for Safety - Collateral standard: Electromagnetic Compatibility - Requirements and Tests Edition 2.1(Edition 2:2001 consolidated with Amendment 1:2004)
3) AAMI / ANSI / ISO 10993-1, Biological evaluation of medical devices -- Part 1: Evaluation and testing (2003)
4) AAMI / ANSI / ISO 10993-5, Biological evaluation of medical devices – Part 5 : Tests for In Vitro Cytoxicity (1999)
5) AAMI / ANSI / ISO 10993-7, Biological evaluation of medical devices - Part 7: Ehylene Oxide Sterilization Residuals. (2001)
6) AAMI / ANSI / ISO 10993-10, Biological evaluation of medical devices – Part 10: Tests for Irritation and Delaved-type (2002)
7) AAMI /ANSI / ISO 11135-1. Sterilization of health care products - Ethylene oxide - Part1: Requirements for the development, validation and routine control of a sterilization process for medical devices.
8) AAMI /ANSI / ISO 11607-1, Packaging for terminally sterilized medical devices -Part1: Requirements for materials, sterile barriersystems and packaging systems, 3ed (2006)
9) AAMI /ANSI / ISO 11607-2, Packaging for terminally sterilized medical devices -Part 2: Validation requirements for forming, sealing and assembly process, 1ed (2006)
{3}------------------------------------------------
Traditional 510(k) N 510(k) Summar Mar 25, 2011
DOLPHIN® 3 Gyrus ACMI, Inc. 136 Turnpike Road Southborough, MA 01772
.
# Technological Characteristics and Substantial Equivalence
The DOLPHIN® 3 Hysteroscopic Insufflator is an upgrade to the predicate DOLPHIN® II device currently marketed by Gyrus ACMI, Inc. The DOLPHIN® 3 will be marketed with updated software, hardware, and an additional fluid distension bag. The DOLPHIN® 3 will have the identical indications as the predicate DOLPHIN® II, K011876. The software, mechanical design and tubing set have been updated to accommodate the additional fluid bag. The same bladder bag and self contained pump design, used in the DOLPHIN® II to regulate fluid pressure, is incorporated in the DOLPHIN® 3. The tubing set and integrated transducer remains a single use accessory sterilized by EtO.
In summary, the DOLPHIN® 3 is substantially equivalent to the predicate DOLPHIN® II device and presents no new questions of safety or efficacy.
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus, a symbol often associated with medicine and healthcare, with three parallel lines that curve and flow downwards. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the caduceus.
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002
Mr. Graham Baillie Associate Manager, Regulatory Affairs Gyrus ACMI, Inc. 136 Turnpike Road SOUTHBOROUGH MA 01772
JUL 1 9 2011
Re: K110852
> Trade Name: DOLPHIN®3 Fluid Management System Regulation Number: 21 CFR \$884.1700 Regulation Name: Hysteroscopic insufflator Regulatory Class: II Product Code: HIG Dated: June 23, 2011 Received: June 24, 2011
Dear Mr. Baillie:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related
{5}------------------------------------------------
#### Page 2
adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Hubert Lenoir MD
erbert P. Lerner, M.D., Director (Acting) Division of Reproductive, Gastro-Renal and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health.
#### Enclosure
{6}------------------------------------------------
# Indications for Use
510(k) Number (if known): . K110852
Device Name: _ _ DOLPHIN® 3 Fluid Management System
Indications For Use:
The DOLPHIN® 3 Fluid Management System provides low viscosity liquid distension of the uterus for hysteroscopy, and monitors intrauterine pressure, fluid use and fluid deficit.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Afald Kenn
oductive. Gastro-F nal, and
Page 1 of _____1__
